Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
February 06, 2020 09:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position...
Nymox Provides Update on Current Corporate Activities and Milestones
January 28, 2020 09:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide a current January 2020 update on several important corporate...
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
January 06, 2020 11:00 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report a new peer review research report has been published on experimental...
Nymox Reports on Newly Issued Patents and Corporate Developments
October 21, 2019 09:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report very positive fundamental news, that the Company has received several...
Nymox End of Q2 New Investor Presentation on Website
June 25, 2019 11:45 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide an up-to-date investor communication presentation posted on the Nymox...
Nymox Reports Pre-NDA CMC Meeting with the FDA
April 16, 2019 12:46 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that it has held its pre-New Drug Application (NDA) Chemistry...
Nymox Teleconference Monday, March 25 10:00 a.m. EDT
March 21, 2019 13:45 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Nymox will hold a teleconference for shareholders on Monday, March 25 at 10:00 a.m....
Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)
March 19, 2019 09:45 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that Mark Staples PhD has joined Nymox as Vice President for...
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
March 13, 2019 09:30 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the...
Nymox to Host Investor Teleconference
March 11, 2019 11:53 ET
|
Nymox Pharmaceutical Corporation
HASBROUCK HEIGHTS, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) will hold a teleconference for shareholders on March 25, 2019. Management will discuss the...